Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas

American Journal Of Pathology(2022)10.1016/j.ajpath.2022.01.007Source: DataRank Database

Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas is a research paper published in American Journal Of Pathology (2022). On theSindex it has a DataRank of 0. It has been cited 221 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access221 citations

Download PDF

Cite:

Linked data & code

refseq

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 21.15)OA: greenTopics (18)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (20)

Randall J. Olsen ORCID,Sheng Long ORCID,Richard Snehal,James J. Davis ORCID,Matthew Ojeda Saavedra ORCID

Live enrichment

PubMed:35123975 PMC:PMC8812084 OpenAlex:https://openalex.org/W4210585911

National Institutes of Health

Grant: 75N93019C00076

U.S. Department of Health and Human Services

National Institute of Allergy and Infectious Diseases

FWCI

21.15

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8812084

publisherhttps://api.elsevier.com/content/article/PII:S000294402200044X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S000294402200044X?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ajpath.2022.01.007

Fields of Study

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies

MeSH Terms

COVID-19SARS-CoV-2HospitalizationHumansTexasVaccines

Keywords

Coronavirus disease 2019 (COVID-19)DiseaseMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CoronavirusPandemicEpidemiologyInternal medicineInfectious disease (medical specialty)

Sustainable Development Goals

SDG 0: Good health and well-being